Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 18275 | 4.53 |
09:34 ET | 3297 | 4.525 |
09:36 ET | 4109 | 4.47 |
09:38 ET | 2647 | 4.51 |
09:39 ET | 8180 | 4.58 |
09:41 ET | 2164 | 4.6227 |
09:43 ET | 19806 | 4.59 |
09:45 ET | 3529 | 4.57 |
09:48 ET | 6342 | 4.52 |
09:50 ET | 4490 | 4.485 |
09:52 ET | 8324 | 4.4875 |
09:54 ET | 4499 | 4.5 |
09:56 ET | 603 | 4.49 |
09:57 ET | 4825 | 4.5 |
09:59 ET | 3788 | 4.5134 |
10:01 ET | 4777 | 4.51 |
10:03 ET | 1622 | 4.5 |
10:06 ET | 2649 | 4.5 |
10:08 ET | 1722 | 4.52 |
10:10 ET | 3474 | 4.495 |
10:12 ET | 8625 | 4.49 |
10:14 ET | 2620 | 4.485 |
10:15 ET | 4212 | 4.49 |
10:17 ET | 1400 | 4.5 |
10:19 ET | 32548 | 4.51 |
10:21 ET | 6421 | 4.495 |
10:24 ET | 2448 | 4.505 |
10:26 ET | 300 | 4.51 |
10:28 ET | 800 | 4.5 |
10:30 ET | 14038 | 4.475 |
10:32 ET | 7162 | 4.445 |
10:33 ET | 4574 | 4.5 |
10:37 ET | 1400 | 4.5 |
10:39 ET | 3483 | 4.54 |
10:42 ET | 1596 | 4.57 |
10:44 ET | 2970 | 4.52 |
10:46 ET | 1884 | 4.505 |
10:48 ET | 10971 | 4.505 |
10:50 ET | 8852 | 4.5 |
10:51 ET | 23100 | 4.5 |
10:53 ET | 12150 | 4.49 |
10:55 ET | 5124 | 4.47 |
10:57 ET | 1378 | 4.45 |
11:00 ET | 833 | 4.46 |
11:02 ET | 2105 | 4.475 |
11:04 ET | 9889 | 4.45 |
11:06 ET | 5104 | 4.48 |
11:08 ET | 808 | 4.49 |
11:09 ET | 1100 | 4.51 |
11:11 ET | 500 | 4.54 |
11:13 ET | 500 | 4.54 |
11:15 ET | 2677 | 4.54 |
11:18 ET | 200 | 4.54 |
11:22 ET | 873 | 4.54 |
11:24 ET | 3200 | 4.5 |
11:26 ET | 787 | 4.51 |
11:27 ET | 1219 | 4.52 |
11:29 ET | 1566 | 4.5 |
11:31 ET | 1000 | 4.5 |
11:33 ET | 800 | 4.51 |
11:36 ET | 2849 | 4.48 |
11:38 ET | 2299 | 4.49 |
11:40 ET | 900 | 4.49 |
11:42 ET | 3200 | 4.48 |
11:44 ET | 1900 | 4.5 |
11:45 ET | 6174 | 4.5033 |
11:47 ET | 100 | 4.5 |
11:49 ET | 5290 | 4.52 |
11:51 ET | 1300 | 4.49 |
11:54 ET | 1894 | 4.51 |
11:56 ET | 1200 | 4.5009 |
11:58 ET | 1104 | 4.515 |
12:00 ET | 400 | 4.51 |
12:02 ET | 216 | 4.51 |
12:03 ET | 4669 | 4.5 |
12:05 ET | 400 | 4.505 |
12:07 ET | 300 | 4.5 |
12:09 ET | 400 | 4.5 |
12:12 ET | 100 | 4.5 |
12:14 ET | 500 | 4.51 |
12:16 ET | 2310 | 4.51 |
12:18 ET | 300 | 4.505 |
12:20 ET | 1000 | 4.505 |
12:21 ET | 6662 | 4.51 |
12:23 ET | 200 | 4.51 |
12:25 ET | 100 | 4.51 |
12:27 ET | 300 | 4.51 |
12:30 ET | 200 | 4.51 |
12:32 ET | 100 | 4.515 |
12:34 ET | 5527 | 4.525 |
12:36 ET | 400 | 4.53 |
12:38 ET | 300 | 4.53 |
12:39 ET | 200 | 4.53 |
12:41 ET | 930 | 4.53 |
12:43 ET | 499 | 4.53 |
12:45 ET | 400 | 4.53 |
12:48 ET | 2200 | 4.53 |
12:50 ET | 955 | 4.53 |
12:52 ET | 200 | 4.53 |
12:56 ET | 1875 | 4.53 |
12:57 ET | 200 | 4.53 |
12:59 ET | 600 | 4.53 |
01:01 ET | 9595 | 4.56 |
01:03 ET | 3324 | 4.55 |
01:06 ET | 3224 | 4.57 |
01:08 ET | 327 | 4.57 |
01:10 ET | 140 | 4.58 |
01:14 ET | 400 | 4.58 |
01:15 ET | 200 | 4.58 |
01:17 ET | 700 | 4.58 |
01:19 ET | 2283 | 4.57 |
01:21 ET | 799 | 4.57 |
01:24 ET | 1800 | 4.57 |
01:26 ET | 1547 | 4.565 |
01:28 ET | 300 | 4.565 |
01:30 ET | 200 | 4.565 |
01:32 ET | 860 | 4.58 |
01:33 ET | 200 | 4.575 |
01:35 ET | 556 | 4.58 |
01:37 ET | 500 | 4.58 |
01:39 ET | 2695 | 4.555 |
01:42 ET | 2278 | 4.53 |
01:44 ET | 1729 | 4.55 |
01:48 ET | 500 | 4.54 |
01:53 ET | 100 | 4.55 |
01:55 ET | 600 | 4.5449 |
01:57 ET | 100 | 4.545 |
02:00 ET | 400 | 4.545 |
02:02 ET | 100 | 4.55 |
02:04 ET | 700 | 4.55 |
02:06 ET | 2302 | 4.555 |
02:08 ET | 300 | 4.56 |
02:09 ET | 1800 | 4.54 |
02:11 ET | 3037 | 4.555 |
02:13 ET | 3400 | 4.6 |
02:15 ET | 724 | 4.6 |
02:18 ET | 500 | 4.61 |
02:20 ET | 300 | 4.62 |
02:22 ET | 400 | 4.62 |
02:24 ET | 1200 | 4.62 |
02:26 ET | 1681 | 4.6 |
02:27 ET | 2219 | 4.595 |
02:29 ET | 140 | 4.595 |
02:31 ET | 899 | 4.59 |
02:33 ET | 2358 | 4.6 |
02:36 ET | 300 | 4.61 |
02:38 ET | 100 | 4.61 |
02:40 ET | 1574 | 4.62 |
02:42 ET | 1697 | 4.62 |
02:44 ET | 800 | 4.62 |
02:45 ET | 1945 | 4.61 |
02:47 ET | 500 | 4.6 |
02:49 ET | 300 | 4.6 |
02:51 ET | 600 | 4.605 |
02:54 ET | 4556 | 4.61 |
02:56 ET | 1500 | 4.62 |
02:58 ET | 400 | 4.61 |
03:00 ET | 850 | 4.615 |
03:02 ET | 400 | 4.61 |
03:03 ET | 600 | 4.61 |
03:05 ET | 200 | 4.61 |
03:07 ET | 1200 | 4.625 |
03:09 ET | 1709 | 4.64 |
03:12 ET | 1900 | 4.65 |
03:14 ET | 1300 | 4.64 |
03:16 ET | 1708 | 4.65 |
03:18 ET | 2500 | 4.63 |
03:20 ET | 427 | 4.635 |
03:21 ET | 300 | 4.64 |
03:23 ET | 300 | 4.635 |
03:25 ET | 100 | 4.635 |
03:27 ET | 2542 | 4.645 |
03:30 ET | 7639 | 4.635 |
03:32 ET | 800 | 4.635 |
03:36 ET | 5418 | 4.67 |
03:38 ET | 2200 | 4.665 |
03:39 ET | 9921 | 4.65 |
03:41 ET | 9905 | 4.64 |
03:43 ET | 1460 | 4.63 |
03:45 ET | 5621 | 4.615 |
03:48 ET | 7660 | 4.635 |
03:50 ET | 6595 | 4.625 |
03:52 ET | 900 | 4.625 |
03:54 ET | 26829 | 4.645 |
03:56 ET | 10023 | 4.635 |
03:57 ET | 9122 | 4.625 |
03:59 ET | 28388 | 4.61 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 533.6M | -2.4x | --- |
Iteos Therapeutics Inc | 536.1M | -4.0x | --- |
PureTech Health PLC | 553.5M | -10.3x | --- |
Third Harmonic Bio Inc | 532.3M | -17.2x | --- |
Northwest Biotherapeutics Inc | 516.8M | -6.5x | --- |
Lexeo Therapeutics Inc | 528.4M | -5.8x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $533.6M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.99 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.